Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells

Autor:	Wei, Xiaolong, Yang, Jiekun, Adair, Sara J., Ozturk, Harun, Kuscu, Cem, Lee, Kyung Yong, Kane, William J., O’Hara, Patrick E., Liu, Denis, Demirlenk, Yusuf Mert, Habieb, Alaa Hamdi, Yilmaz, Ebru, Dutta, Anindya, Bauer, Todd W., Adli, Mazhar
Zdroj:	Proceedings of the National Academy of Sciences of the United States of America, 2020 Nov 01. 117(45), 28068-28079.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26970706 Zobrazit plný text záznamu